- Inflexion acquired SteriPack Group in July
- Kinneir Dufort is a user-centred innovation and product development consultancy
- SteriPack is a global contract manufacturer of medical, pharmaceutical and diagnostic products
Inflexion’s portfolio company SteriPack announced today it has acquired Kinneir Dufort (KD), a user-centred design and product development firm. For Mobeus, which sells its stake in KD, the exit delivers 2.8x MoC and 28 percent IRR. The MoC could rise to up to 3.0x if KD achieves “certain financial objectives post completion”, said Mobeus.
Based in Bristol in the UK, KD provides its consultancy and innovation services to medical, consumer and industrial clients globally.
SteriPack Group, headquartered in Lakeland, Florida, is a full-service contract manufacturer serving global medical device, diagnostic and pharmaceutical customers.
The sale of KD is the fourth exit from Mobeus Equity Partners IV. The firm initially backed the buyout of KD in 2016. Under London-based Mobeus’ ownership, KD has advanced its internal systems and processes to enable the business to scale efficiently and expanded its management team and client base. The the quality of earnings of the business has “markedly increased” by focusing on the medical devices sector, according to Mobeus.
Headquartered in London, Inflexion is a middle-market private equity firm that backs both majority and minority investments.
Mobeus backs entrepreneurial, fast-growth UK businesses across all sectors.